PROKProKidney
About ProKidney
ProKidney (NASDAQ:PROK) is a pioneer in regenerative medicine with a focus on kidney diseases. The company's main objective is to transform the treatment landscape for patients suffering from chronic kidney disease (CKD) and end-stage renal disease (ESRD) through innovative regenerative medicine therapies. ProKidney's leading project, REACT (Renal Autologous Cell Therapy), aims to delay or prevent the need for dialysis or transplantation by regenerating the patient's own kidney cells. By harnessing the body's natural healing process, ProKidney is dedicated to improving patients' quality of life and reducing the healthcare system's burden posed by kidney diseases.
What is PROK known for?
Snapshot
Public US
Ownership
2015
Year founded
131
Employees
North Carolina, United States
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United States
Produtos e/ou serviços de ProKidney
- Regenerative Medicine Solutions - Focused on developing therapies to treat chronic kidney disease through cellular and regenerative methods.
- Clinical Trials - Conducts advanced clinical trials for innovative kidney disease treatments, aiming at enhancing patient health.
- Stem Cell Research - Invests heavily in stem cell technology to pioneer breakthrough treatments for kidney regeneration.
- Patient Care Programs - Offers comprehensive care programs designed to support patients throughout their treatment journey.
- Educational Outreach - Provides resources and education to patients and healthcare professionals on kidney health.
- Technology Development - Continues to develop and refine technologies that support its core mission of treating chronic kidney diseases.
equipe executiva do ProKidney
- Dr. Bruce Culleton M.D.CEO & Director
- Dr. Ulrich Ernst Ph.D.EVP of Science and Technology
- Mr. Todd C. Girolamo Esq., J.D., M.B.A.Chief Legal Officer & Secretary
- Mr. James Coulston CPAChief Financial Officer
- Ms. Anu BiswasSenior VP of Manufacturing & Operations
- Mr. Richard WilliamsChief Information Officer
- Ms. Carla PoulsonChief People Officer
- Dr. Joseph M. Stavas M.D., M.P.H.SVP of Clinical Affairs
- Dr. Darin J. Weber Ph.D.Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access
- Mr. Nikhil L. Pereira-KamathChief Business Officer